Home
|
News
|
Events
|
Contact Us
|
English
|
繁體中文
|
日本語
About Us
Product & Service
Facilities
Quality & Compliance
For Investors
Career
|
Company
|
Milestone
|
People
|
Mission Statement
|
Organization
|
Contact Us
|
|
Active Pharmaceutical Ingredients
|
Contract Development and Manufacturing Organization (CDMO)
|
Antibody Drug Conjugates (ADCs)
|
Injectable Manufacturing Services
|
|
Kilo Lab
|
Commercial Production
|
High Potency API (HPAPI)
|
Analytical instrument
|
|
DMFs & CEPs
|
Inspection
|
Certificates
|
SHE Policy
|
Intellectual Property
|
Award
|
|
Financials
|
Corporate Governance
|
Shareholder Services
|
CSR
|
FAQ
About Us
Home
/
About Us
/
News
/
Formosa Laboratories, Formosa Pharmaceuticals and HCmed Signed MoU to Form a Global CDMO for Inhalation Treatment Drugs
Formosa Laboratories, Formosa Pharmaceuticals and HCmed Signed MoU to Form a Global CDMO for Inhalation Treatment Drugs
more
next»
2022-03-07
Please click here for details:
https://www.prnewswire.com/news-releases/hcmed-formosa-laboratories-and-formosa-pharmaceuticals-signed-mou-to-form-a-global-cdmo-for-inhalation-treatment-drugs-301495583.html
Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.
丙肝
